prasad1
Active member
Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP), TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in providing "high-quality, low-cost generic medicines essential for health care around the world".
This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after the Obama Modi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders' consultations on related policy matters.
India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.
While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama's visit to India assume significance not only for the Indian pharma industry but for patients across the world.
Promote Indian drugs, US health groups urge Obama - The Times of India
This comes in the wake of the two nations agreeing to enhance engagement on IPR at the latest bilateral talks. Sunday's joint statement after the Obama Modi meeting said the two countries expressed interest in sharing information and best practices on IPR, and reaffirmed commitment to stakeholders' consultations on related policy matters.
India is a major manufacturer and exporter of low cost generic medicines. The domestic pharmaceutical industry registered exports worth $14.84 billion in the 2013-14. While the US itself contributes the majority of this sales, India is also a major supplier of generic medicines to other parts of the world.
While India is currently in the process of finalizing an IPR policy and a separate policy for pricing of patented medicines in the country, bilateral talks between the two nations along with Obama's visit to India assume significance not only for the Indian pharma industry but for patients across the world.
Promote Indian drugs, US health groups urge Obama - The Times of India
